AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32682994 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sugar and carbohydrate education (LSC) + TLE (16‐h fast/8‐h feed for 5 days per week) + blinded CGM
Number of subjects: 60
Study 32682994 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sugar and carbohydrate education (LSC) + TLE + real time feedback via CGM
Number of subjects: 60
Study 35609059 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-male participants with highest dichotomy of Lipoprotein(a)
Number of subjects: 253
Study 35609059 — intervention group
Group type: COMPARATOR
Intervention: Control-male participants with highest dichotomy of Lipoprotein(a)
Number of subjects: 253
Study 35609059 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-female participants with highest dichotomy of C-Peptide
Number of subjects: 253
Study 35609059 — intervention group
Group type: COMPARATOR
Intervention: Control-male participants with highest dichotomies of Atherogenic Index of Plasma and Castelli Risk Index I
Number of subjects: 253
Study 35609059 — intervention group
Group type: EXPERIMENTAL
Intervention: Case participants with highest quartile of C-Peptide
Number of subjects: 253
Study 35609059 — intervention group
Group type: COMPARATOR
Intervention: Control participants with higher atherogenic indices of plasma and anthropometric values
Number of subjects: 253
Study 33235447 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol-inhaled amikacin
Number of subjects: 144
Study 33235447 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral probiotics
Number of subjects: 144
Study 33235447 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined vaccination
Number of subjects: 144
Study 33235447 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study 33242071 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy rehabilitation
Number of subjects: 67
Study 33242071 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with a weighted vest (WALK)
Number of subjects: 67
Study 33242071 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 67
Study 33242071 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined NMES/Walk
Number of subjects: 67
Study 35305906 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-Coated Balloon (PCB) (SeQuent Please, B. Braun Melsungen; 3 μg/mm2)
Number of subjects: 70
Study 35305906 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-Coated Balloon (SCB) (SeQuent SCB, B. Braun Melsungen; 4 μg/mm2)
Number of subjects: 70
Study 33026766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide topical solution, 45% (HP45)
Number of subjects: 157
Study 33026766 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 157
Study 34606174 — intervention group
Group type: EXPERIMENTAL
Intervention: VEC (vincristine, etoposide, and carboplatin)
Number of subjects: 164
Study 34606174 — intervention group
Group type: COMPARATOR
Intervention: CyVEC (cyclophosphamide, vincristine, etoposide, and carboplatin)
Number of subjects: 164
Study 34606174 — intervention group
Group type: EXPERIMENTAL
Intervention: ICRB A/B/C
Number of subjects: 164
Study 34606174 — intervention group
Group type: COMPARATOR
Intervention: ICRB D/E
Number of subjects: 164
Study 33422764 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitative exercise
Number of subjects: 60
Study 33422764 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline sVAP‐1 concentrations
Number of subjects: 60
Study 32617691 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face training
Number of subjects: 384
Study 32617691 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 384
Study 34379740 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV)
Number of subjects: 0
Study 34379740 — intervention group
Group type: COMPARATOR
Intervention: Baseline oxygen requirement
Number of subjects: 0
Study 34348982 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care interventions (specific interventions not detailed)
Number of subjects: 23
Study 34528074 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 28
Study 34529025 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) followed by Lenalidomide maintenance therapy
Number of subjects: 54
Study 33874968 — intervention group
Group type: EXPERIMENTAL
Intervention: Yarrow liver compresses applied externally once daily during radiation therapy (RT)
Number of subjects: 24
Study 33874968 — intervention group
Group type: COMPARATOR
Intervention: Palliative radiation therapy (RT) alone
Number of subjects: 24
Study 33874968 — intervention group
Group type: EXPERIMENTAL
Intervention: Yarrow liver compresses
Number of subjects: 24
Study 35820664 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluid HIV self-test
Number of subjects: 170
Study 35820664 — intervention group
Group type: COMPARATOR
Intervention: Blood-based HIV self-test
Number of subjects: 170
Study 33775203 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodized training group (PG), n = 25
Number of subjects: 50
Study 33775203 — intervention group
Group type: COMPARATOR
Intervention: Non-periodized training group (NPG), n = 25
Number of subjects: 50
Study 32706343 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet concentrates (APC), specifically platelet rich fibrin (PRF) and platelet rich plasma (PRP)
Number of subjects: 7
Study 32706343 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet concentrates (APC)
Number of subjects: 7
Study 32706343 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 7
Study 35595645 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-weeks of low-load blood-flow restricted (BFR) resistance training
Number of subjects: 20
Study 35595645 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-exercising)
Number of subjects: 20
Study 32712606 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 48
Study 33506314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcifediol 20 µg/day
Number of subjects: 50
Study 33506314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcifediol 30 µg/day
Number of subjects: 50
Study 33506314 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 50
Study 35809362 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (TE2)
Number of subjects: 73
Study 35809362 — intervention group
Group type: COMPARATOR
Intervention: Transdermal placebo
Number of subjects: 73
Study 33771116 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic saline (IS)
Number of subjects: 38
Study 33771116 — intervention group
Group type: COMPARATOR
Intervention: PlasmaLyte (PL)
Number of subjects: 38
Study 32079472 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 82
Study 32079472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 35843037 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) fiber
Number of subjects: 29
Study 35843037 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 29
Study 33780655 — intervention group
Group type: EXPERIMENTAL
Intervention: Large facilities
Number of subjects: 17194
Study 33780655 — intervention group
Group type: COMPARATOR
Intervention: Smaller facilities
Number of subjects: 17194
Study 33780655 — intervention group
Group type: EXPERIMENTAL
Intervention: Not independently mobile
Number of subjects: 17194
Study 33780655 — intervention group
Group type: EXPERIMENTAL
Intervention: Male residents
Number of subjects: 17194
Study 33780655 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents with dementia
Number of subjects: 17194
Study 33780655 — intervention group
Group type: EXPERIMENTAL
Intervention: Random selection of participants
Number of subjects: 17194
Study 32390168 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI monotherapy (nivolumab: 44.3%, pembrolizumab: 11.7%, ipilimumab: 23.6%)
Number of subjects: 451
Study 32390168 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI combination therapy
Number of subjects: 451
Study 32390168 — intervention group
Group type: COMPARATOR
Intervention: Definite PAI
Number of subjects: 451
Study 32390168 — intervention group
Group type: COMPARATOR
Intervention: Possible PAI
Number of subjects: 451
Study 35758433 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenchyma-sparing resections (PSR)
Number of subjects: 810
Study 35758433 — intervention group
Group type: COMPARATOR
Intervention: Oncologic resections
Number of subjects: 810
Study 35758433 — intervention group
Group type: COMPARATOR
Intervention: No lymph nodes resected
Number of subjects: 810
Study 32023539 — intervention group
Group type: COMPARATOR
Intervention: Placebo (daily for 12 weeks)
Number of subjects: 19
Study 36309971 — intervention group
Group type: EXPERIMENTAL
Intervention: PB-201
Number of subjects: 672
Study 36309971 — intervention group
Group type: COMPARATOR
Intervention: Vildagliptin
Number of subjects: 672
Study 36309971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 672
Study 34281913 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose atorvastatin
Number of subjects: 0
Study 34281913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32699287 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HW) 1.5 L/d for 4 weeks
Number of subjects: 38
Study 32699287 — intervention group
Group type: COMPARATOR
Intervention: Plain water (PW)
Number of subjects: 38
Study 35761257 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing carried out by trained laypeople using manual toothbrush
Number of subjects: 39
Study 35761257 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing carried out by trained laypeople using powered toothbrush
Number of subjects: 39
Study 35761257 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing carried out by dental professionals using manual toothbrush
Number of subjects: 39
Study 35761257 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing carried out by dental professionals using powered toothbrush
Number of subjects: 39
Study 35761257 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 39
Study 34118150 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceval bioprosthesis
Number of subjects: 0
Study 34118150 — intervention group
Group type: COMPARATOR
Intervention: Standard sutured stented bioprosthetic aortic valve
Number of subjects: 0
Study 34118150 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 32565465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v probiotic therapy in addition to usual care
Number of subjects: 220
Study 32565465 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to usual care
Number of subjects: 220
Study 32930640 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone group (SMA), n = 11, used social network smartphone apps for 30 minutes before training.
Number of subjects: 22
Study 32930640 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON), n = 11, watched Olympic Games videos for 30 minutes before training.
Number of subjects: 22
Study 33528922 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.2 to 1.5 μg/kg/hour)
Number of subjects: 422
Study 33528922 — intervention group
Group type: COMPARATOR
Intervention: Propofol (5 to 50 μg/kg/min)
Number of subjects: 422
Study 35278403 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 0
Study 35278403 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32299733 — intervention group
Group type: EXPERIMENTAL
Intervention: G-Series media system with antioxidants (A3 group)
Number of subjects: 133
Study 32299733 — intervention group
Group type: COMPARATOR
Intervention: G-Series media system (control)
Number of subjects: 133
Study 36305584 — intervention group
Group type: EXPERIMENTAL
Intervention: Active system
Number of subjects: 65
Study 36305584 — intervention group
Group type: COMPARATOR
Intervention: Sham system
Number of subjects: 65
Study 34656099 — intervention group
Group type: EXPERIMENTAL
Intervention: TruNatomy
Number of subjects: 60
Study 34656099 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper GOLD
Number of subjects: 60
Study 34656099 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne GOLD
Number of subjects: 60
Study 33074237 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfotiamine
Number of subjects: 70
Study 33074237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35857978 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard inner limiting membrane peeling
Number of subjects: 59
Study 35857978 — intervention group
Group type: EXPERIMENTAL
Intervention: Inner limiting membrane peeling with abrasion technique
Number of subjects: 59
Study 34397951 — intervention group
Group type: EXPERIMENTAL
Intervention: Packed red blood cells (PRBCs) transfusion
Number of subjects: 399
Study 34397951 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantity of PRBCs transfused
Number of subjects: 399
Study 32539705 — intervention group
Group type: EXPERIMENTAL
Intervention: ESRD patients with depression
Number of subjects: 30
Study 35404772 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruption of sedatives
Number of subjects: 85
Study 35404772 — intervention group
Group type: COMPARATOR
Intervention: Volume assist-control mode
Number of subjects: 85
Study 35404772 — intervention group
Group type: COMPARATOR
Intervention: Pressure support mode
Number of subjects: 85
Study 32583630 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 60
Study 32583630 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 60
Study 35613997 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT plus pembrolizumab (Group A)
Number of subjects: 150
Study 35613997 — intervention group
Group type: EXPERIMENTAL
Intervention: CCRT plus pembrolizumab with olaparib (Group B)
Number of subjects: 150
Study 35613997 — intervention group
Group type: COMPARATOR
Intervention: CCRT plus placebo (Group C)
Number of subjects: 150
Study 33970327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (CF) 400 mg for 7 days
Number of subjects: 17
Study 33970327 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 17
Study 35120559 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured learning program, prehospital NIHSS, and a mobile application facilitating communication with the stroke physician.
Number of subjects: 1300
Study 35120559 — intervention group
Group type: COMPARATOR
Intervention: Standard procedures (control phase).
Number of subjects: 1300
Study 33959750 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculant (INO) containing Lactobacillus buchneri and Pediococcus pentosaceus (4 × 10^5 and 1 × 10^5 cfu/g of fresh corn)
Number of subjects: 6
Study 33959750 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) without inoculant
Number of subjects: 6
Study 32356923 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized security checks (30% screened)
Number of subjects: 0
Study 32356923 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized security checks (90% screened)
Number of subjects: 0
Study 32356923 — intervention group
Group type: COMPARATOR
Intervention: Traditional security checks
Number of subjects: 0
Study 35453121 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tDCS
Number of subjects: 11
Study 35453121 — intervention group
Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 11
Study 35024014 — intervention group
Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 60
Study 36229117 — intervention group
Group type: EXPERIMENTAL
Intervention: iSOMA guided (8-week intervention with regular, written therapeutic guidance)
Number of subjects: 149
Study 36229117 — intervention group
Group type: COMPARATOR
Intervention: iSOMA-GoD (guidance-on-demand after waitlist control)
Number of subjects: 149
Study 36229117 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (iSOMA guided and iSOMA-GoD)
Number of subjects: 149
Study 33336703 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time ultrasound (RTUS) visual feedback with manual facilitation
Number of subjects: 25
Study 33336703 — intervention group
Group type: COMPARATOR
Intervention: Manual facilitation alone
Number of subjects: 25
Study 34590986 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral-integrated musical rhythms intervention, conducted over five sessions.
Number of subjects: 38
Study 34590986 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in the abstract).
Number of subjects: 38
Study 34237458 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental placebo manipulations (e.g., positive expectations, time spent with subjects, training for accurate symptom reporting)
Number of subjects: 0
Study 34237458 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions that neutralize staff and subject expectations and improve reporting accuracy
Number of subjects: 0
Study 32000687 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC)
Number of subjects: 50
Study 32000687 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (CC)
Number of subjects: 50
Study 32000687 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LC and CC
Number of subjects: 50
Study 34348574 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg
Number of subjects: 1048
Study 34348574 — intervention group
Group type: COMPARATOR
Intervention: Secukinumab 300 mg
Number of subjects: 1048
Study 33048477 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE)
Number of subjects: 10
Study 33048477 — intervention group
Group type: COMPARATOR
Intervention: Water (Control)
Number of subjects: 10
Study 32147444 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise plus motor imagery
Number of subjects: 37
Study 32147444 — intervention group
Group type: COMPARATOR
Intervention: Only home exercise
Number of subjects: 37
Study 36326471 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (0.05 mg/kg)
Number of subjects: 15
Study 36326471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32041632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficient children (serum 25(OH)D < 12 ng/ml)
Number of subjects: 791
Study 32041632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D inadequate children (serum 25(OH)D 12-20 ng/ml)
Number of subjects: 791
Study 32041632 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D sufficient children (serum 25(OH)D > 20 ng/ml)
Number of subjects: 791
Study 35768894 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention based on reciprocity
Number of subjects: 17930
Study 35768894 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention based on scarcity
Number of subjects: 17930
Study 35768894 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention based on authority
Number of subjects: 17930
Study 34429160 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 1146
Study 34429160 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID + MTX
Number of subjects: 1146
Study 34429160 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week + MTX
Number of subjects: 1146
Study 35289857 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor necrosis factor inhibitors (TNFis) for at least 12 weeks
Number of subjects: 1899
Study 35289857 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher C-reactive protein (CRP) level, patient global assessment (PGA), and Bath AS Disease Activity Index (BASDAI) question 2 score
Number of subjects: 1899
Study 35289857 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher body mass index (BMI) and Bath AS Functional Index (BASFI) score
Number of subjects: 1899
Study 35289857 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and BASFI score
Number of subjects: 1899
Study 35289857 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher CRP level, BASDAI question 2 score, and PGA
Number of subjects: 1899
Study 32066436 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic lateral patella retinaculum releasing outside synovial membrane (OSM)
Number of subjects: 125
Study 32066436 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic lateral patella retinaculum releasing through synovial membrane (TSM)
Number of subjects: 125
Study 34103514 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroscience publications from African institutions
Number of subjects: 5219
Study 34103514 — intervention group
Group type: COMPARATOR
Intervention: Publications from the UK, USA, Australia, Japan, and Brazil (control group)
Number of subjects: 5219
Study 32659854 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-epiglottis transnasal tube insertion
Number of subjects: 60
Study 34385272 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 1265162 200 µg twice daily
Number of subjects: 28
Study 34385272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 32892245 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-spin prepared PRP injection
Number of subjects: 15
Study 32892245 — intervention group
Group type: COMPARATOR
Intervention: Single-spin prepared PRP injection
Number of subjects: 15
Study 36317099 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary sternal closure
Number of subjects: 217
Study 36317099 — intervention group
Group type: COMPARATOR
Intervention: Vacuum-assisted closure
Number of subjects: 217
Study 32660025 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (L. plantarum, L. bulgaricus, L. gasseri, B. breve, B. animalis sbsp. lactis, B. bifidum, S. thermophilus, and S. boulardii)
Number of subjects: 60
Study 32660025 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34906756 — intervention group
Group type: EXPERIMENTAL
Intervention: Numen coil
Number of subjects: 350
Study 34906756 — intervention group
Group type: COMPARATOR
Intervention: Axium coil
Number of subjects: 350
Study 34244750 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (IG) with clinical pharmacist's interventions
Number of subjects: 256